Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 50 M49 M46 M50 M49 M 194 M Research & development ————— — Operating income 64 M-964 M-1.68 B240 M287 M -2.11 B Non-Operating Income, Total -104 M-129 M-220 M-158 M-270 M -777 M Interest expense, net of interest capitalized 116 M112 M154 M173 M276 M 715 M Non-Operating Income, excl. Interest Expenses -108 M-102 M-142 M-160 M-277 M -681 M Unusual income/expense 4 M-27 M-78 M2 M7 M -96 M Pretax income -40 M-1.09 B-1.9 B82 M17 M -2.89 B Equity in earnings ———-1 M— — Taxes 39 M-155 M26 M57 M-54 M -126 M Non-controlling/minority interest ————— — After tax other income/expense -4 M-27 M18 M-1 M1 M -9 M Net income before discontinued operations -79 M-938 M-1.92 B25 M71 M -2.77 B Discontinued operations ————— — Net income -79 M-938 M-1.92 B25 M71 M -2.77 B Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders -108 M-909 M-1.92 B25 M71 M -2.74 B Basic earnings per share (Basic EPS) -0.09-1.06-20.110.06 -2.89 Diluted earnings per share (Diluted EPS) -0.11-1.06-20.130.06 -2.87 Average basic shares outstanding 883 M888 M961 M960 M1.11 B — Diluted shares outstanding 958 M888 M961 M960 M1.12 B — EBITDA 238 M340 M398 M388 M426 M 1.55 B EBIT 62 M165 M237 M241 M283 M 926 M Cost of revenue 618 M599 M584 M605 M606 M 2.39 B Other cost of goods sold ————— — Depreciation & amortization (cash flow) 176 M175 M161 M147 M143 M 626 M